REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | -33.3% | 4,528 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +28.6% | 4,528 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +75.0% | 4,528 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 4,528 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -85.3% | 4,528 | 0.0% | 0.00% | – |
| Q3 2015 | $34,000 | +6.2% | 4,528 | 0.0% | 0.00% | – |
| Q2 2015 | $32,000 | -77.1% | 4,528 | -72.3% | 0.00% | – |
| Q1 2015 | $140,000 | -0.7% | 16,352 | +15.9% | 0.00% | – |
| Q4 2014 | $141,000 | +0.7% | 14,103 | 0.0% | 0.00% | – |
| Q3 2014 | $140,000 | -45.9% | 14,103 | -5.7% | 0.00% | – |
| Q2 2014 | $259,000 | -13.4% | 14,948 | -11.4% | 0.00% | – |
| Q1 2014 | $299,000 | +4.5% | 16,875 | +7.8% | 0.00% | – |
| Q4 2013 | $286,000 | -25.5% | 15,651 | +9.1% | 0.00% | – |
| Q3 2013 | $384,000 | +82.9% | 14,346 | +26.1% | 0.00% | – |
| Q2 2013 | $210,000 | – | 11,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |